Protagenic Therapeutics
New York
About Protagenic Therapeutics
Protagenic Therapeutics Inc. is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.3M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2024)
- Ticker: otcqb:PTIX
- Website: protagenic.com
- Phone: 212-994-8202
Industries & Categories
Biotechnology, Developer Platform, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/protagenic-therapeutics-116557 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.